Pfizer Inc. (PFE)
27.98
-0.09
(-0.32%)
USD |
NYSE |
Aug 24, 16:00
27.96
-0.02
(-0.07%)
After-Hours: 20:00
Pfizer 1 Year Total Returns (Daily) : 16.73% for Aug. 21, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 21, 2026 | 16.73% |
| August 20, 2026 | 17.21% |
| August 19, 2026 | 19.39% |
| August 18, 2026 | 16.35% |
| August 17, 2026 | 14.41% |
| August 14, 2026 | 14.20% |
| August 13, 2026 | 14.02% |
| August 12, 2026 | 14.25% |
| August 11, 2026 | 15.93% |
| August 10, 2026 | 17.80% |
| August 07, 2026 | 18.22% |
| August 06, 2026 | 17.20% |
| August 05, 2026 | 11.63% |
| August 04, 2026 | 15.59% |
| August 03, 2026 | 14.06% |
| July 31, 2026 | 14.95% |
| July 30, 2026 | 11.99% |
| July 29, 2026 | 10.79% |
| July 28, 2026 | 11.18% |
| July 27, 2026 | 6.52% |
| July 24, 2026 | 5.42% |
| July 23, 2026 | 5.55% |
| July 22, 2026 | 5.66% |
| July 21, 2026 | 10.02% |
| July 20, 2026 | 8.25% |
| Date | Value |
|---|---|
| July 17, 2026 | 9.07% |
| July 16, 2026 | 9.33% |
| July 15, 2026 | 7.94% |
| July 14, 2026 | 2.38% |
| July 13, 2026 | 2.14% |
| July 10, 2026 | 0.34% |
| July 09, 2026 | 1.54% |
| July 08, 2026 | 0.46% |
| July 07, 2026 | 2.06% |
| July 06, 2026 | 0.02% |
| July 02, 2026 | 2.80% |
| July 01, 2026 | 2.07% |
| June 30, 2026 | 6.32% |
| June 29, 2026 | 7.82% |
| June 26, 2026 | 7.24% |
| June 25, 2026 | 4.42% |
| June 24, 2026 | 5.83% |
| June 23, 2026 | 10.10% |
| June 22, 2026 | 11.98% |
| June 18, 2026 | 12.98% |
| June 17, 2026 | 15.59% |
| June 16, 2026 | 14.22% |
| June 15, 2026 | 13.39% |
| June 12, 2026 | 12.93% |
| June 11, 2026 | 14.41% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Johnson & Johnson | 54.80% |
| Eli Lilly & Co. | 77.98% |
| Merck & Co., Inc. | 83.18% |
| Bristol Myers Squibb Co. | 44.96% |
| Viatris, Inc. | 59.76% |